Iron-eliminating protein key factor in breast cancer: study
Page 1 of 1 • Share
Iron-eliminating protein key factor in breast cancer: study
[You must be registered and logged in to see this image.]
WASHINGTON: A protein that eliminates iron from cells could be used to slow the growth of cancerous tumors, to treat breast cancer, and to predict the outcome for breast cancer patients, a study published Wednesday found.
Researchers at Wake Forest University Baptist Medical Center in North Carolina found that levels of ferroportin -- a protein that exports iron from cells -- are strikingly lower in breast tumors than in normal tissue.
The lack of ferroportin results in a build-up of iron, which allows a tumor to grow and perhaps become more aggressive, Suzy Torti, an associate professor of biochemistry at Wake Forest Baptist and one of the lead investigators on the study published in Science Translational Medicine, said.
When the researchers restored ferroportin levels to normal in human breast tumors in mice, the tumors grew more slowly.
"Because ferroportin can remove iron from the cell, when we put the protein back into the cell, the ferroportin removed the cancer's growth stimulus," said Torti.
"Our findings suggest that ferroportin is a substantial influence on the behavior of the cancer," she said.
Patients should not, however, change the amount of iron in their diets, she stressed, because the study was focused on cellular, not dietary iron.
The researchers also looked at data on more than 800 women with breast cancer to see if they could find a link between ferroportin levels and long-term outcomes for cancer.
They found that low ferroportin levels were a strong predictor of a poor outcome for women with breast cancer and that ferroportin levels were lowest in the most aggressive areas of cancer.
But they also had good news: high levels of ferroportin predicted a 90-percent chance that a woman would be a long-term cancer survivor.
"Using ferroportin as a marker for iron regulation may be a useful tool in breast cancer prognosis and may even help direct therapy," the study said.
"In the future, manipulating levels of ferroportin or proteins that affect levels of ferroportin may prove to be an effective breast cancer treatment," it said.
WASHINGTON: A protein that eliminates iron from cells could be used to slow the growth of cancerous tumors, to treat breast cancer, and to predict the outcome for breast cancer patients, a study published Wednesday found.
Researchers at Wake Forest University Baptist Medical Center in North Carolina found that levels of ferroportin -- a protein that exports iron from cells -- are strikingly lower in breast tumors than in normal tissue.
The lack of ferroportin results in a build-up of iron, which allows a tumor to grow and perhaps become more aggressive, Suzy Torti, an associate professor of biochemistry at Wake Forest Baptist and one of the lead investigators on the study published in Science Translational Medicine, said.
When the researchers restored ferroportin levels to normal in human breast tumors in mice, the tumors grew more slowly.
"Because ferroportin can remove iron from the cell, when we put the protein back into the cell, the ferroportin removed the cancer's growth stimulus," said Torti.
"Our findings suggest that ferroportin is a substantial influence on the behavior of the cancer," she said.
Patients should not, however, change the amount of iron in their diets, she stressed, because the study was focused on cellular, not dietary iron.
The researchers also looked at data on more than 800 women with breast cancer to see if they could find a link between ferroportin levels and long-term outcomes for cancer.
They found that low ferroportin levels were a strong predictor of a poor outcome for women with breast cancer and that ferroportin levels were lowest in the most aggressive areas of cancer.
But they also had good news: high levels of ferroportin predicted a 90-percent chance that a woman would be a long-term cancer survivor.
"Using ferroportin as a marker for iron regulation may be a useful tool in breast cancer prognosis and may even help direct therapy," the study said.
"In the future, manipulating levels of ferroportin or proteins that affect levels of ferroportin may prove to be an effective breast cancer treatment," it said.
Zeba Khan Hoti- Monstars
- Posts : 773
Join date : 2011-02-24
Similar topics
» From iron fist to iron bars: Mubarak goes on trial
» Should you eat protein before exercise, or after?
» Protein 'early clue' to Alzheimer's
» Misbah backs Akhtar factor against India
» Cricket World Cup: Pakistan grapple with Sri Lanka M-factor
» Should you eat protein before exercise, or after?
» Protein 'early clue' to Alzheimer's
» Misbah backs Akhtar factor against India
» Cricket World Cup: Pakistan grapple with Sri Lanka M-factor
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Yesterday at 10:48 am by ali001
» Storybook Magic App
Tue Apr 30, 2024 7:06 pm by ali001
» Flower Book Match3 Puzzle Game
Tue Apr 30, 2024 12:17 pm by ali001
» Avian Influenza Symptom in Chickens "Bird Flu H5N1 Virus" Vet learning materials, Poultry Farming
Sat Apr 27, 2024 9:57 am by Ibad Khan Buledi
» house disrepair claims
Mon Apr 22, 2024 11:23 am by Joshuaadam
» Aloha Planner - Note-Taker
Thu Apr 11, 2024 4:52 pm by ali001
» Streaming Guide Film TV Series
Tue Apr 09, 2024 9:39 pm by ali001
» Apricot Tree Problems & Solutions ????|خوبانی کے پھل کو کیڑا لگنےسے بچانے کا طریقہ ????
Sun Apr 07, 2024 6:28 am by Zamaan Khan
» خوبانی کے پودے کی کاشت گرم علاقوں میں کرنی چاہیے یا نہی
Sun Apr 07, 2024 6:24 am by Zamaan Khan